Processa Pharmaceuticals (PCSA) Change in Accrued Expenses (2012 - 2026)
Processa Pharmaceuticals (PCSA) reported Change in Accrued Expenses of -$412,258 for Q2 2026, compared with $582,496 a year earlier.
Powered by 
Analysis
Processa Pharmaceuticals (PCSA) Change in Accrued Expenses (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Processa Pharmaceuticals' Change in Accrued Expenses came in at -$535,778; for FY2025, it was $600,726, up 38.9% from FY2024.
- Change in Accrued Expenses has a five-year compound annual growth rate of 49.0% (FY2020 to FY2025).
- By year, Change in Accrued Expenses came in at $432,457 in FY2024, -$256,787 in FY2023, $243,796 in FY2022 and -$65,411 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Change in Accrued Expenses in data going back to Q3 2012.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$39,734 (Q1 2026), $155,651 (Q4 2025) and -$239,437 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Processa Pharmaceuticals | 5.22 Mn | -8.52 Mn | - | -412,258.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -412,258.00 |
| Mar 31, 2026 | -39,734.00 |
| Dec 31, 2025 | 155,651.00 |
| Sep 30, 2025 | -239,437.00 |
| Jun 30, 2025 | 582,496.00 |
| Mar 31, 2025 | 102,016.00 |
| Dec 31, 2024 | 165,918.00 |
| Sep 30, 2024 | -92,584.00 |
| Jun 30, 2024 | 39,779.00 |
| Mar 31, 2024 | 319,344.00 |
| Dec 31, 2023 | -55,962.00 |
| Sep 30, 2023 | -109,266.00 |
| Jun 30, 2023 | 48,416.00 |
| Mar 31, 2023 | -139,975.00 |
| Dec 31, 2022 | 306,654.00 |
| Sep 30, 2022 | -91,005.00 |
| Jun 30, 2022 | 14,846.00 |
| Mar 31, 2022 | 13,301.00 |
| Dec 31, 2021 | -189,395.00 |
| Sep 30, 2021 | -20,450.00 |
API Access
Processa Pharmaceuticals Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PCSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "PCSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=PCSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();